SAFE Compounded Drugs Act Could Expand FDA Regulatory Power

Posted on

Compounding pharmacies have been in the news as of late following a fungal meningitis outbreak that stemmed from contaminated steroids distributed by the New England Compounding Center.  The House of Representatives, in a bid to ensure safety from these types of outbreaks in the future, is looking into the possible passage of a bill known as the SAFE Compounded Drugs Act.  If passed, the Food and Drug Administration would be tasked with compiling production standards that compounders would have to meet.  A database of these facilities would also be put together, and state officials would be subject to FDA training on how to monitor these institutions.

Follow this link to learn more about the bill.